Categories AlphaGraphs, Earnings, Health Care

Vertex Pharmaceuticals reports 14% growth in Q1 revenue: Infographic

Vertex Pharmaceuticals (NASDAQ: VRTX) reported first-quarter 2021 financial results after the regular market hours on Thursday. The pharmaceutical firm reported Q1 revenue of $1.72 billion, up 14% year-over-year and above the Wall Street projection. Net income of $2.98 per share was also above the target that analysts had anticipated.

VRTX shares were down 0.4% immediately following the announcement. The stock has fallen 7% since the beginning of this year.

Vertex Pharma Q1 2021 earnings

Looking forward to listening to management / analyst comments on the results? Stay tuned here for Vertex Pharmaceuticals Q1 earnings call transcript

Prior performance

Most Popular

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Target (TGT): A look at some of the challenges faced by the retailer in 3Q24

Shares of Target Corporation (NYSE: TGT) stayed green on Thursday, recovering from the stumble it took a day ago after delivering disappointing results for the third quarter of 2024 and

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top